L & S Advisors »

Vaneck Vectors Pharmaceutical etf shares owned by L & S Advisors

Quarter-by-quarter ownership of Vaneck Vectors Pharmaceutical etf (PPH) shares owned by L & S Advisors from 13F filings

Historical chart of L & S Advisors investment in Vaneck Vectors Pharmaceutical etf

Tip: Access up to 7 years of quarterly data

All positions including Vaneck Vectors Pharmaceutical etf held by L & S Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaneck Vectors Pharmaceutical etf by L & S Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $273k 2.9k 95.03
2024-06-30 $270k 2.9k 91.48
2024-03-31 $268k 3.0k 90.70

More positions owned by L & S Advisors

Spdr S&p 500 Etf (SPY)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Facebook Inc cl a (META)
Spdr Blackstone Senior Loan Fixed (SRLN)
Broadcom (AVGO)
SPDR Dow Jones Industrial Average ETF (DIA)
Palo Alto Networks (PANW)
Intuitive Surgical (ISRG)
Servicenow (NOW)
JPMorgan Chase & Co. (JPM)
Digital Realty Trust (DLR)
Wal-Mart Stores (WMT)

View all positions for L & S Advisors

Top funds holding Vaneck Vectors Pharmaceutical etf

Goldman Sachs Group
Healthcare Of Ontario Pension Plan Trust Fund
Avalon Trust
J.Safra Asset Management
Mivtachim The Workers Social Insurance Fund
Miller Investment Management
Thrivent Financial for Lutherans
Adamsbrown Wealth Consultants
Two Sigma Investments
Prime Capital Investment Advisors
Bank of America Corporation
Morgan Stanley
Susquehanna International
Bnp Paribas Arbitrage, Snc
Independent Advisor Alliance

View all funds holding Vaneck Vectors Pharmaceutical etf